Phase I and preliminary phase 0 results of ABTC 1801: A multi-arm clinical trial of the PARP inhibitor pamiparib (BGB290) with very low dose metronomic temozolomide in recurrent IDH mutant gliomas Meeting Abstract
| Authors: | Schiff, D.; Bindra, R.; Li, J.; Ye, X.; Ellingson, B.; Walbert, T.; Campian, J.; Nabors, L. B.; Lieberman, F.; Ozer, B.; Desai, A.; Omuro, A.; Wen, P.; Desideri, S.; Fisher, J.; Grossman, S. |
| Abstract Title: | Phase I and preliminary phase 0 results of ABTC 1801: A multi-arm clinical trial of the PARP inhibitor pamiparib (BGB290) with very low dose metronomic temozolomide in recurrent IDH mutant gliomas |
| Meeting Title: | 26th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 23 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2021 Nov 18-21 |
| Meeting Location: | Boston, MA |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-11-01 |
| Start Page: | vi63 |
| Language: | English |
| ACCESSION: | WOS:000757356200245 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/noab196.243 |
| Notes: | Meeting Abstract: CTNI-18 -- Source: Wos |
